-
Je něco špatně v tomto záznamu ?
Decrease in serum calcitriol (but not free 25-hydroxyvitamin D) concentration in hip fracture healing
J. Vaculik, L. Wenchich, M. Bobelyak, K. Pavelka, JJ. Stepan
Jazyk angličtina Země Itálie
Typ dokumentu časopisecké články
Grantová podpora
00023728
Ministerstvo zdravotnictví České Republiky (CZ)
- MeSH
- fraktury kyčle krev MeSH
- hojení fraktur fyziologie MeSH
- kalcitriol krev MeSH
- lidé MeSH
- náhrada kyčelního kloubu MeSH
- osteogeneze MeSH
- parathormon krev MeSH
- prospektivní studie MeSH
- referenční hodnoty MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- vitamin D analogy a deriváty krev MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
OBJECTIVE: To assess the decrease in serum calcitriol concentrations after hip fracture. METHODS: Serum concentrations of calcitriol, 25(OH)D, parathyroid hormone (PTH), directly measured free 25(OH)D, and indices of bone formation were measured in elderly patients with hip fracture (HF) and patients with elective hip replacement (EHR) at admission and after 7 weeks. RESULTS: A total of 45 patients with HF and 17 patients with EHR completed this prospective study. Baseline serum calcitriol levels were ≤ 60 pmol/l in 26% of the HF patients. After 7 weeks, they significantly decreased (p < 0.001). In patients with EHR, serum calcitriol was within the reference range in all but one patient and did not change during the 7-week recovery phase. Seven weeks after HF, a significant positive relationship was observed between the change in calcitriol and serum 25(OH)D concentration (r = 0.385, p = 0.009) and free 25(OH)D (r = 0.296, p = 0.048), and a decrease in calcitriol during recovery was associated with a decrease in serum PTH (p = 0.038). Seven weeks after HF, changes in both serum PTH and serum 25(OH)D concentrations contributed to the prediction of changes in serum calcitriol (R2 = 0.190, p = 0.012). CONCLUSIONS: Unlike patients with EHR, subjects with HF had low serum 25(OH)D and low free 25(OH)D concentrations at admission, while their serum 1,25D levels were relatively elevated. Decreases in circulating calcitriol levels in the 7 weeks following hip surgery were associated with a resolution of secondary hyperparathyroidism and low availability of free 25(OH)D.
Faculty of Medicine 1 Charles University Prague Czech Republic
Faculty of Medicine 3 Charles University Prague Czech Republic
Institute of Rheumatology Prague Czech Republic
Orthopedic Department Bulovka Hospital Prague Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22012251
- 003
- CZ-PrNML
- 005
- 20220506130020.0
- 007
- ta
- 008
- 220425s2021 it f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s40618-020-01489-x $2 doi
- 035 __
- $a (PubMed)33492601
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a it
- 100 1_
- $a Vaculik, J $u Orthopedic Department, Bulovka Hospital, Prague, Czech Republic $u Faculty of Medicine 1, Charles University, Prague, Czech Republic $u Faculty of Medicine 3, Charles University, Prague, Czech Republic
- 245 10
- $a Decrease in serum calcitriol (but not free 25-hydroxyvitamin D) concentration in hip fracture healing / $c J. Vaculik, L. Wenchich, M. Bobelyak, K. Pavelka, JJ. Stepan
- 520 9_
- $a OBJECTIVE: To assess the decrease in serum calcitriol concentrations after hip fracture. METHODS: Serum concentrations of calcitriol, 25(OH)D, parathyroid hormone (PTH), directly measured free 25(OH)D, and indices of bone formation were measured in elderly patients with hip fracture (HF) and patients with elective hip replacement (EHR) at admission and after 7 weeks. RESULTS: A total of $a OBJECTIVE To assess the decrease in serum calcitriol concentrations after hip fracture METHODS Serum concentrations of calcitriol 25 OH D parathyroid hormone PTH directly measured free 25 OH D and indices of bone formation were measured in elderly patients with hip fracture HF and patients with elective hip replacement EHR at admission and after 7 weeks RESULTS A total of 45 patients wit $a OBJECTIVE: To assess the decrease in serum calcitriol concentrations after hip fracture. METHODS: Serum concentrations of calcitriol, 25(OH)D, parathyroid hormone (PTH), directly measured free 25(OH)D, and indices of bone formation were measured in elderly patients with hip fracture (HF) and patients with elective hip replacement (EHR) at admission and after 7 weeks. RESULTS: A total of 45 patients with HF and 17 patients with EHR completed this prospective study. Baseline serum calcitriol levels were ≤ 60 pmol/l in 26% of the HF patients. After 7 weeks, they significantly decreased (p < 0.001). In patients with EHR, serum calcitriol was within the reference range in all but one patient and did not change during the 7-week recovery phase. Seven weeks after HF, a significant positive relationship was observed between the change in calcitriol and serum 25(OH)D concentration (r = 0.385, p = 0.009) and free 25(OH)D (r = 0.296, p = 0.048), and a decrease in calcitriol during recovery was associated with a decrease in serum PTH (p = 0.038). Seven weeks after HF, changes in both serum PTH and serum 25(OH)D concentrations contributed to the prediction of changes in serum calcitriol (R2 = 0.190, p = 0.012). CONCLUSIONS: Unlike patients with EHR, subjects with HF had low serum 25(OH)D and low free 25(OH)D concentrations at admission, while their serum 1,25D levels were relatively elevated. Decreases in circulating calcitriol levels in the 7 weeks following hip surgery were associated with a resolution of secondary hyperparathyroidism and low availability of free 25(OH)D.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a náhrada kyčelního kloubu $7 D019644
- 650 _2
- $a kalcitriol $x krev $7 D002117
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a hojení fraktur $x fyziologie $7 D017102
- 650 _2
- $a fraktury kyčle $x krev $7 D006620
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a osteogeneze $7 D010012
- 650 _2
- $a parathormon $x krev $7 D010281
- 650 _2
- $a prospektivní studie $7 D011446
- 650 _2
- $a referenční hodnoty $7 D012016
- 650 _2
- $a vitamin D $x analogy a deriváty $x krev $7 D014807
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Wenchich, L $u Institute of Rheumatology, Prague, Czech Republic
- 700 1_
- $a Bobelyak, M $u Orthopedic Department, Bulovka Hospital, Prague, Czech Republic $u Faculty of Medicine 3, Charles University, Prague, Czech Republic
- 700 1_
- $a Pavelka, K $u Faculty of Medicine 1, Charles University, Prague, Czech Republic $u Institute of Rheumatology, Prague, Czech Republic
- 700 1_
- $a Stepan, J J $u Faculty of Medicine 1, Charles University, Prague, Czech Republic. stepan@revma.cz $u Institute of Rheumatology, Prague, Czech Republic. stepan@revma.cz $1 https://orcid.org/0000000315418306 $7 jn20000402905
- 773 0_
- $w MED00002652 $t Journal of endocrinological investigation $x 1720-8386 $g Roč. 44, č. 9 (2021), s. 1847-1855
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33492601 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220425 $b ABA008
- 991 __
- $a 20220506130012 $b ABA008
- 999 __
- $a ok $b bmc $g 1789719 $s 1163452
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 44 $c 9 $d 1847-1855 $e 20210125 $i 1720-8386 $m Journal of endocrinological investigation $n J Endocrinol Invest $x MED00002652
- GRA __
- $a 00023728 $p Ministerstvo zdravotnictví České Republiky (CZ)
- LZP __
- $a Pubmed-20220425